These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9255565)

  • 1. Biomarkers of gene expression: growth factors and oncoproteins.
    Brandt-Rauf PW
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):807-16. PubMed ID: 9255565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers of carcinogenesis.
    Brandt-Rauf PW; Pincus MR
    Pharmacol Ther; 1998 Feb; 77(2):135-48. PubMed ID: 9578321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene and tumor-suppressor gene products as serum biomarkers in occupational-derived lung cancer.
    Helmig S; Schneider J
    Expert Rev Mol Diagn; 2007 Sep; 7(5):555-68. PubMed ID: 17892364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of blood serum oncoprotein NEU and antioncoprotein p-53--molecular biomarkers in various types of occupational exposure.
    Krajewska B; Lutz W; Piłacik B
    Int J Occup Med Environ Health; 1998; 11(4):343-8. PubMed ID: 10028201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual interactions between p53 and growth factors in cancer.
    Asschert JG; Vellenga E; De Jong S; de Vries EG
    Anticancer Res; 1998; 18(3A):1713-25. PubMed ID: 9673395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of P53, NPM1, Kras, c-Myc, p14(ARF) genes in blood cells of cancer patients before and after radiation therapy].
    Shulenina LV; Ushenkova LN; Ledin EV; Shagirova ZhM; Raeva NF; Zasukhina GD; Mikhaĭlov VF
    Radiats Biol Radioecol; 2012; 52(6):572-81. PubMed ID: 23516888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma YKL-40: a potential new cancer biomarker?
    Johansen JS; Schultz NA; Jensen BV
    Future Oncol; 2009 Sep; 5(7):1065-82. PubMed ID: 19792974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular epidemiology of growth signal transduction proteins.
    Brandt-Rauf PW; De Vivo I; Marion MJ; Hemminki K
    J Occup Environ Med; 1995 Jan; 37(1):77-83. PubMed ID: 7620946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
    Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
    Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers associated with prostate cancer progression.
    Zhau HE; Pisters LL; Hall MC; Zhao LS; Troncoso P; Pollack A; Chung LW
    J Cell Biochem Suppl; 1994; 19():208-16. PubMed ID: 7529853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody biomarkers in the detection of cancer.
    Cho-Chung YS
    Biochim Biophys Acta; 2006 Jun; 1762(6):587-91. PubMed ID: 16730166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
    Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
    Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers identified to predict esophageal cancer susceptibility and aspirin found to lower cancer risk.
    Future Oncol; 2007 Apr; 3(2):127. PubMed ID: 17381411
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum p53 and bladder cancer: can serum p53 be used as a tumor marker?
    Malviya V; Singh H; Dwivedi US; Usha ; Singh PB
    Urol Res; 2004 Dec; 32(6):391-4. PubMed ID: 15503000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rules of tumor cell development and their application to biomarkers for ovarian cancer.
    McLemore MR; Miaskowski C; Aouizerat BE; Chen LM; Dodd M
    Oncol Nurs Forum; 2008 May; 35(3):403-9. PubMed ID: 18467290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scope of growth factor in cancer patients.
    Parvez T; Almazaini A; Al Bouq Y; Al-Hazmi OA; Al-Ahmadi YM
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):375-7. PubMed ID: 15924849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
    Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
    Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress of oncogene and tumor suppressor gene in bladder cancer.
    Zhang X; Han C; He J
    Panminerva Med; 2015 Dec; 57(4):191-200. PubMed ID: 25634585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumour markers of pancreatic cancer--Part II (molecular markers of carcinogenesis and non-specific tumour markers)].
    Groblewska M; Mroczko B; Karpiuk E; Szmitkowski M
    Pol Arch Med Wewn; 2005 Nov; 114(5):1118-27. PubMed ID: 16789513
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoxia related growth factors and p53 in preoperative sera from patients with colorectal cancer--evaluation of the prognostic significance of these agents.
    Sulkowski S; Wincewicz A; Zalewski B; Famulski W; Lotowska JM; Koda M; Sobaniec-Lotowska ME; Mysliwiec M; Baltaziak M; Pawlak K; Sulkowska M
    Clin Chem Lab Med; 2009; 47(11):1439-45. PubMed ID: 19817649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.